COLONY NORTHSTAR, INC. (NYSE:CLNS) Files An 8-K Financial Statements and Exhibits

COLONY NORTHSTAR, INC. (NYSE:CLNS) Files An 8-K Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.

Story continues below

(a) Financial statements of businesses acquired

The financial statements of Colony NorthStar Credit, CLNS Investment Entities, NorthStar I and NorthStar II required to be filed to Rule 3-05 of Regulation S-X are incorporated herein by reference to Exhibits 99.1, 99.2, 99.3 and 99.4, respectively.

(b) Pro forma financial information

The pro forma financial information of the Company required to be filed in connection with the acquisition and disposition described in Item 9.01 in the Original 8-K is incorporated herein by reference to Exhibit 99.5 of this Current Report on Form 8-K/A.

(d) Exhibits


Colony NorthStar, Inc. Exhibit
EX-23.1 2 exh231consent-clncopinion.htm CONSENT OF ERNST & YOUNG LLP Exhibit EXHIBIT 23.1 Consent of Independent Registered Public Accounting FirmWe consent to the incorporation by reference in the following Registration Statements:    (1)Registration Statement (Form S-8 No. 333-215509) of Colony NorthStar,…
To view the full exhibit click here

About COLONY NORTHSTAR, INC. (NYSE:CLNS)

Colony NorthStar, Inc. is a diversified equity real estate investment trust (REIT). The Company combines a portfolio of real assets across the world, which are managed with a global real estate investment manager. The Company has property holdings in the healthcare, industrial and hospitality sectors, opportunistic equity and debt investments, and an embedded institutional and retail investment management business. In addition, the Company owns NorthStar Securities, LLC, a captive broker-dealer platform which raises capital in the retail market. The Company acquires, develops and operates industrial properties in metropolitan markets throughout the United States with a focus on light industrial buildings. The Company provides investment management services and offers investment products while serving as a fiduciary to a set of institutional and individual investors.

An ad to help with our costs